首页 | 本学科首页   官方微博 | 高级检索  
检索        

尿激酶溶栓治疗老年急性心肌梗死临床观察
引用本文:孙玉芬,秦桂华,钟德针.尿激酶溶栓治疗老年急性心肌梗死临床观察[J].中国煤炭工业医学杂志,2002,5(8):804-805.
作者姓名:孙玉芬  秦桂华  钟德针
作者单位:1. 201600,上海市松江社会福利院
2. 内蒙古牙克石市人民医院
3. 内蒙古林业总医院
摘    要:目的:探讨尿激酶溶栓治疗老年人急性心肌梗死(AMI)的疗效及安全性,方法:选择老年急性心肌梗死患者共60例,作为观察对象,一组为溶栓治疗组共28例,给予国产尿激酶静脉溶栓治疗,另一组32例未溶栓治疗,两组进行疗效观察,结果:静脉溶栓组死亡率,严重并发症少,心衰及严重心律失常发生率明显低于未溶栓(P<0.05),结论:尿激酶治疗老年急性心肌梗死安全有效。

关 键 词:尿激酶溶栓  治疗  老年  急性心肌梗死  临床观察
文章编号:1007-9564(2002)08-0804-02
修稿时间:2002年2月22日

CLINICAL OBSERVATION OF UROKINASE THROMBOLYTIC THERAPY FOR AMI IN THE AGED
Sun Yufen,Qin Guihua,Zhong Dezhen,Sunjiang Social Welfare Hospital of Shanghai.CLINICAL OBSERVATION OF UROKINASE THROMBOLYTIC THERAPY FOR AMI IN THE AGED[J].Chinese Journal of Coal Industry Medicine,2002,5(8):804-805.
Authors:Sun Yufen  Qin Guihua  Zhong Dezhen  Sunjiang Social Welfare Hospital of Shanghai
Institution:Sun Yufen,Qin Guihua,Zhong Dezhen,Sunjiang Social Welfare Hospital of Shanghai,201600
Abstract:Objective To study the safety and effects of Urokinase thrombolytic therapy for aged patients with acute myocardial infarction (AMI). Methods 60 aged patients with AMI were observed, including 28 cases treated with intravenous Urokinase as therapy group and the other 32 cases as control group. Results Compared with the control group, the therapy group showed low mortality rate, less severe complications and decreased heart failure or serious cardiac arrhythmia (P<0.05). Conclusion Intravenous thrombolytic Urokinase is both safe and effective in the treatment of aged AMI.
Keywords:Urokinase Aged Myocardial infarction
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号